Bruker Corporation
BRKR
$39.93
$0.621.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.45% | -0.41% | 11.04% | 14.64% | 16.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.45% | -0.41% | 11.04% | 14.64% | 16.37% |
| Cost of Revenue | 1.99% | 7.40% | 11.90% | 14.50% | 21.93% |
| Gross Profit | -2.95% | -8.31% | 10.18% | 14.78% | 11.17% |
| SG&A Expenses | 5.48% | 4.56% | 15.42% | 17.98% | 28.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1,220.59% | 62.07% | 143.75% | -861.11% | 6.25% |
| Total Operating Expenses | -2.60% | 6.91% | 14.17% | 14.53% | 25.67% |
| Operating Income | 16.88% | -64.79% | -13.95% | 15.19% | -27.12% |
| Income Before Tax | -231.76% | -95.36% | -64.48% | -77.41% | -53.89% |
| Income Tax Expenses | -195.27% | -119.25% | -56.06% | 9.70% | -51.95% |
| Earnings from Continuing Operations | -245.16% | -44.74% | -67.69% | -93.21% | -54.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -283.33% | -- | 154.55% | -122.22% | 200.00% |
| Net Income | -245.72% | 0.00% | -65.82% | -93.33% | -53.58% |
| EBIT | 16.88% | -64.79% | -13.95% | 15.19% | -27.12% |
| EBITDA | 14.21% | -33.15% | 3.91% | 20.72% | -7.05% |
| EPS Basic | -252.26% | -2.91% | -67.26% | -93.60% | -55.07% |
| Normalized Basic EPS | 19.25% | -70.64% | -26.48% | 12.74% | -32.04% |
| EPS Diluted | -252.26% | 0.00% | -68.57% | -93.58% | -55.00% |
| Normalized Diluted EPS | 19.62% | -70.52% | -26.26% | 12.82% | -31.92% |
| Average Basic Shares Outstanding | 0.20% | 2.85% | 4.41% | 4.19% | 3.34% |
| Average Diluted Shares Outstanding | -0.13% | 2.50% | 4.11% | 4.11% | 3.19% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.00% | -0.01% | 2.09% | 14.62% | 1.21% |